Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth-Reference-Cited by-同舟云学术

Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth

Published:2015-09-02 Issue:7568 Volume:525 Page:206-211
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Zhu Jiajun,Sammons Morgan A.,Donahue Greg,Dou Zhixun,Vedadi Masoud,Getlik Matthäus,Barsyte-Lovejoy Dalia,Al-awar Rima,Katona Bryson W.,Shilatifard Ali,Huang Jing,Hua Xianxin,Arrowsmith Cheryl H.,Berger Shelley L.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature15251.pdf

Reference42 articles.

1. Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495–501 (2014)

2. Lang, G. A. et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119, 861–872 (2004)

3. Olive, K. P. et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847–860 (2004)

4. Freed-Pastor, W. A. et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 148, 244–258 (2012)

5. Zhang, C. et al. Tumour-associated mutant p53 drives the Warburg effect. Nat. Commun. 4, 2935 (2013)

Cited by 388 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CXCR2 chemokine receptor: A new target for gastric cancer therapy;Cytokine;2024-09

2. Mutant p53 Exploits Enhancers to Elevate Immunosuppressive Chemokine Expression and Impair Immune Checkpoint Inhibitors in Pancreatic Cancer;2024-08-30

3. Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns;Nature Communications;2024-08-27

4. Multi-omic and functional screening reveal targetable vulnerabilities inTP53mutated multiple myeloma;2024-08-23

5. Pyrimidine Triones as Potential Activators of p53 Mutants;Biomolecules;2024-08-08